Toufic Tannous
Hematology & Oncology · Albuquerque, NMNPI 1619495058
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 8.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,315, 6.8 times the $485 reported in 2019.
Across 121 payments — averaging $79.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$841
- Daiichi Sankyo Inc.$764
- Regeneron Healthcare Solutions, Inc.$732
- Johnson & Johnson$686
- Jazz Pharmaceuticals Inc.$535
- AstraZeneca$500
- plus $6K from 30 others
What the payments were for
- Food & beverage$9,45598%
- Education$2002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 8 | $841 |
| Daiichi Sankyo Inc. | 11 | $764 |
| Regeneron Healthcare Solutions, Inc. | 6 | $732 |
| Johnson & Johnson | 11 | $686 |
| Jazz Pharmaceuticals Inc. | 5 | $535 |
| AstraZeneca(2 entities) | 9 | $500 |
| E.r. Squibb & Sons, L.L.C. | 5 | $472 |
| Astellas Pharma US Inc | 5 | $472 |
| Janssen Scientific Affairs, LLC | 4 | $454 |
| Pfizer | 7 | $451 |
| Sanofi | 4 | $387 |
| Gilead(2 entities) | 6 | $349 |
| Amgen | 3 | $319 |
| Incyte Corporation | 2 | $254 |
| EMD Serono, Inc. | 4 | $249 |
| AbbVie | 2 | $245 |
| Eisai Inc. | 2 | $237 |
| Genentech USA, Inc. | 2 | $148 |
| Karyopharm Therapeutics Inc. | 1 | $146 |
| Adaptive Biotechnologies Corporation | 2 | $134 |
| Beone Medicines USA, Inc. | 1 | $131 |
| Merck | 1 | $124 |
| Recordati_rare_diseases_inc. | 2 | $123 |
| Pharmacosmos Therapeutics Inc. | 2 | $121 |
| Seagen Inc. | 1 | $119 |
| Tempus AI, Inc | 1 | $116 |
| Genentech, Inc. | 1 | $113 |
| ADC Therapeutics America, Inc. | 1 | $111 |
| Genmab U.S., Inc. | 1 | $106 |
| Beigene USA, Inc. | 2 | $49 |
| Array Biopharma Inc | 3 | $38 |
| Acrotech Biopharma Inc. | 2 | $35 |
| Servier Pharmaceuticals LLC | 1 | $27 |
| Kyowa Kirin, Inc. | 1 | $27 |
| Springworks Therapeutics, Inc. | 1 | $23 |
| Bristol Myers Squibb | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,655 in reported general payments places this provider in the 70th percentile of 54 hematology & oncology providers in New Mexico.
Other hematology & oncology in Albuquerque
- Ursa Brown GlabermanAlbuquerque$219K
- Neda Hashemi SadraeiAlbuquerque$96K
- Muhammad TarakjiAlbuquerque$34K
- Yara AbdouAlbuquerque$25K
- George AtwehAlbuquerque$24K
- Scott HerbertAlbuquerque$14K
- Jose AvitiaAlbuquerque$11K
- Zoneddy DayaoAlbuquerque$10K
- Amy TarnowerAlbuquerque$5K
- Bernard TawfikAlbuquerque$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.